查看購物車
  • Simplified Chinese
  • English
封面
市場調查報告書
商品編碼
1548181

全球止血與組織封閉劑市場研究報告 - 2024 年至 2032 年產業分析、規模、佔有率、成長、趨勢與預測

Global Hemostasis and Tissue Sealing Agents Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032
出版日期: | 出版商: Value Market Research | 英文 181 Pages | 商品交期: 最快1-2個工作天內

價格

全球止血和組織封閉劑市場需求預計將從 2023 年的 85.2 億美元達到 2032 年近 193.1 億美元的市場規模，2024-2032 年研究期間複合年成長率為 9.51%。

止血和組織封閉劑是用於外科手術過程中控制出血和促進組織修復的醫療產品。這些藥物包括局部止血劑、密封劑和黏合劑，旨在透過促進凝塊形成或密封組織來快速止血。這些試劑通常用於各種外科專業，可以源自生物材料，例如膠原蛋白或纖維蛋白，也可以是合成的。它們的主要功能是透過減少出血相關併發症和促進更快的癒合來提高手術效果。這些產品直接應用於出血部位或組織界面，以實現有效止血並確保組織黏附。

市場動態

心血管、骨科和普通外科等不同醫療領域的外科手術數量不斷增加，推動了止血和組織封閉劑市場的發展。微創手術的需求不斷成長，需要有效的止血和密封解決方案來控制出血和促進康復，這進一步支持了市場成長。技術進步，例如開發具有更高功效和生物相容性的先進密封劑配方，帶來了重大機會。透過創新止血產品減少手術併發症和改善患者治療效果的關注推動了市場擴張。此外，需要手術干預的慢性病和創傷病例的日益流行也導致了這些藥物的使用增加。隨著醫療保健基礎設施和手術能力的不斷擴大，新興市場也為止血和組織封閉劑提供了成長潛力。然而，高成本和潛在的過敏反應可能會抑制止血劑和組織封閉劑的發展。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具也對全球止血和組織密封劑市場的各個細分市場進行了包容性評估。止血和組織密封劑產業的成長和趨勢為本研究提供了整體方法。

市場區隔

止血和組織密封劑市場報告的這一部分提供了有關國家和區域級別細分市場的詳細資料，從而幫助戰略家確定相應產品或服務的目標人口統計數據以及即將到來的機會。

按產品分類

  • 局部止血劑（主動式、機械式、流動式）
  • 黏合劑和組織密封劑（合成組織密封劑、天然組織密封劑、黏連屏障產品）

按材質

  • 明膠局部止血劑
  • 膠原蛋白局部止血劑
  • 基於 ORC 的局部止血劑
  • 多醣體局部止血劑

按申請

  • 一般外科
  • 神經外科
  • 血管外科
  • 心血管外科
  • 其他

按最終用途

  • 醫院
  • 門診手術中心
  • 其他

區域分析

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲止血和組織密封劑市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。止血和組織密封劑市場的主要參與者包括強生公司、CryoLife Inc.、Advance Medical Solution (AMS) Group Plc.、Cohera Medical Inc.、Integra Life Sciences Corporation、輝瑞公司、BD、Baxter、HyperBranch Medical技術、Biomet Inc、B Braun Medical Inc、Smith & Nephew。本節包含競爭格局的整體視圖，包括各種策略發展，例如關鍵併購、未來產能、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

目錄

第1章：前言

  • 報告說明
    • 客觀的
    • 目標受眾
    • 獨特的銷售主張 (USP) 和產品
  • 研究範圍
  • 研究方法
    • 市場研究過程
    • 市場研究方法論

第 2 章：執行摘要

  • 市場亮點
  • 全球市場概況

第 3 章：止血與組織封閉劑 - 產業分析

  • 簡介 - 市場動態
  • 市場促進因素
  • 市場限制
  • 機會
  • 產業動態
  • 波特五力分析
  • 市場吸引力分析
    • 按產品分類的市場吸引力分析
    • 按材料分類的市場吸引力分析
    • 市場吸引力分析：依應用分類
    • 按最終用途分類的市場吸引力分析
    • 市場吸引力分析：按地區

第 4 章：價值鏈分析

  • 價值鏈分析
  • 原料分析
    • 原料清單
    • 原料廠商清單
    • 主要原物料價格走勢
  • 潛在買家名單
  • 行銷管道
    • 直效行銷
    • 間接行銷
    • 行銷通路發展趨勢

第 5 章：全球止血與組織封閉劑市場分析：依產品

  • 概述（按產品）
  • 按產品分類的歷史和預測資料分析
  • 局部止血劑（主動式、機械式、流動式）
  • 黏合劑和組織密封劑（合成組織密封劑、天然組織密封劑、黏連屏障產品）

第 6 章：全球止血與組織封閉劑市場分析：依材料分類

  • 按材料概述
  • 按材料進行的歷史和預測數據分析
  • 明膠局部止血劑
  • 膠原蛋白局部止血劑
  • 基於 ORC 的局部止血劑
  • 多醣體局部止血劑

第 7 章：全球止血與組織封閉劑市場分析：按應用分類

  • 概述：按應用
  • 歷史和預測數據分析：按應用
  • 一般外科
  • 神經外科
  • 血管外科
  • 心血管外科
  • 其他

第 8 章：全球止血與組織封閉劑市場分析：依最終用途分類

  • 按最終用途分類的概述
  • 按最終用途分類的歷史和預測資料分析
  • 醫院
  • 門診手術中心
  • 其他

第 9 章：全球止血與組織封閉劑市場分析：依地理位置

  • 區域展望
  • 介紹
  • 北美銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 北美按細分市場銷售分析
    • 北美按國家銷售分析
    • 美國銷售分析
    • 加拿大銷售分析
    • 墨西哥銷售分析
  • 歐洲銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 歐洲按細分市場銷售分析
    • 歐洲按國家銷售分析
    • 英國銷售分析
    • 法國銷售分析
    • 德國銷售分析
    • 義大利銷售分析
    • 俄羅斯銷售分析
    • 歐洲其他地區銷售分析
  • 亞太地區銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 亞太地區按細分市場銷售分析
    • 亞太地區按國家銷售分析
    • 中國銷售分析
    • 印度銷售分析
    • 日本銷售分析
    • 韓國銷售分析
    • 澳洲銷售分析
    • 東南亞銷售分析
    • 亞太地區其他地區銷售分析
  • 拉丁美洲銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 拉丁美洲按細分市場銷售分析
    • 拉丁美洲按國家銷售分析
    • 巴西銷售分析
    • 阿根廷銷售分析
    • 秘魯銷售分析
    • 智利銷售分析
    • 拉丁美洲其他地區銷售分析
  • 中東和非洲銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 中東和非洲按細分市場銷售分析
    • 中東和非洲按國家銷售分析
    • 沙烏地阿拉伯銷售分析
    • 阿拉伯聯合大公國銷售分析
    • 以色列銷售分析
    • 南非銷售分析
    • 中東其他地區和非洲銷售分析

第 10 章：止血劑和組織封閉劑公司的競爭格局

  • 止血和組織封閉劑市場競爭
  • 夥伴關係/協作/協議
  • 併購
  • 新產品發布
  • 其他發展

第 11 章：公司簡介

  • 頂級公司市佔率分析
  • 市場集中度
  • Johnson & Johnson
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • CryoLife Inc.
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Advance Medical Solution (AMS) Group Plc.
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Cohera Medical Inc.
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Integra Life Sciences Corporation
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Pfizer Inc.
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • BD
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Baxter
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • HyperBranch Medical Technology
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Biomet Inc
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • B Braun Medical Inc
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Smith & Nephew
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態

註 - 在公司概況中，財務詳細資料和最新進展視情況而定，或對私人公司而言可能不包括在內

Product Code: VMR112115538

The global demand for Hemostasis and Tissue Sealing Agents Market is presumed to reach the market size of nearly USD 19.31 Billion by 2032 from USD 8.52 Billion in 2023 with a CAGR of 9.51% under the study period 2024-2032.

Hemostasis and tissue sealing agents are medical products utilized to control bleeding and facilitate tissue repair during surgical procedures. These agents, including topical hemostats, sealants, and adhesives, are designed to quickly stop bleeding by promoting clot formation or sealing tissues. Commonly used in various surgical specialties, these agents can be derived from biological materials, such as collagen or fibrin, or be synthetic. Their primary function is to enhance surgical outcomes by reducing bleeding-related complications and promoting faster healing. These products are applied directly to the bleeding site or tissue interface to achieve effective hemostasis and secure tissue adhesion.

MARKET DYNAMICS

The hemostasis and tissue sealing agents market is fuelled by the increasing number of surgical procedures across diverse medical fields, including cardiovascular, orthopedic, and general surgery. The propelling demand for minimally invasive surgeries, which require effective hemostatic and sealing solutions to manage bleeding and enhance recovery, further supports market growth. Technological advancements, such as developing advanced sealant formulations with improved efficacy and biocompatibility, present significant opportunities. The focus on reducing surgical complications and improving patient outcomes through innovative hemostatic products drives market expansion. Additionally, the growing prevalence of chronic conditions and trauma cases that necessitate surgical intervention contributes to the increased use of these agents. With expanding healthcare infrastructure and surgical capabilities, emerging markets also offer growth potential for hemostasis and tissue sealing agents. However, high costs and potential allergic reactions may restrain the growth of hemostasis and tissue sealing agents.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Hemostasis and Tissue Sealing Agents. The growth and trends of Hemostasis and Tissue Sealing Agents industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Hemostasis and Tissue Sealing Agents market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

  • Topical Hemostat (Active, Mechanical, Flowable)
  • Adhesive & Tissue Sealant (Synthetic Tissue Sealant, Natural Tissue Sealant, Adhesion Barrier Products)

By Material

  • Gelatin-Based Topical Hemostats
  • Collagen-Based Topical Hemostats
  • ORC-based Topical Hemostats
  • Polysaccharide-Based Topical Hemostats

By Application

  • General Surgery
  • Neurosurgery
  • Vascular Surgery
  • Cardiovascular Surgery
  • Others

By End-use

  • Hospitals
  • Ambulatory Surgical Centers
  • Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Hemostasis and Tissue Sealing Agents market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Hemostasis and Tissue Sealing Agents market include Johnson & Johnson, CryoLife Inc., Advance Medical Solution (AMS) Group Plc., Cohera Medical Inc., Integra Life Sciences Corporation, Pfizer Inc., BD, Baxter, HyperBranch Medical Technology, Biomet Inc, B Braun Medical Inc, Smith & Nephew. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. HEMOSTASIS AND TISSUE SEALING AGENTS - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Product
    • 3.7.2 Market Attractiveness Analysis By Material
    • 3.7.3 Market Attractiveness Analysis By Application
    • 3.7.4 Market Attractiveness Analysis By End-use
    • 3.7.5 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL HEMOSTASIS AND TISSUE SEALING AGENTS MARKET ANALYSIS BY PRODUCT

  • 5.1. Overview By Product
  • 5.2. Historical and Forecast Data Analysis By Product
  • 5.3. Topical Hemostat (Active, Mechanical, Flowable) Historic and Forecast Sales By Regions
  • 5.4. Adhesive & Tissue Sealant (Synthetic Tissue Sealant, Natural Tissue Sealant, Adhesion Barrier Products) Historic and Forecast Sales By Regions

6. GLOBAL HEMOSTASIS AND TISSUE SEALING AGENTS MARKET ANALYSIS BY MATERIAL

  • 6.1. Overview By Material
  • 6.2. Historical and Forecast Data Analysis By Material
  • 6.3. Gelatin-Based Topical Hemostats Historic and Forecast Sales By Regions
  • 6.4. Collagen-Based Topical Hemostats Historic and Forecast Sales By Regions
  • 6.5. ORC-based Topical Hemostats Historic and Forecast Sales By Regions
  • 6.6. Polysaccharide-Based Topical Hemostats Historic and Forecast Sales By Regions

7. GLOBAL HEMOSTASIS AND TISSUE SEALING AGENTS MARKET ANALYSIS BY APPLICATION

  • 7.1. Overview By Application
  • 7.2. Historical and Forecast Data Analysis By Application
  • 7.3. General Surgery Historic and Forecast Sales By Regions
  • 7.4. Neurosurgery Historic and Forecast Sales By Regions
  • 7.5. Vascular Surgery Historic and Forecast Sales By Regions
  • 7.6. Cardiovascular Surgery Historic and Forecast Sales By Regions
  • 7.7. Others Historic and Forecast Sales By Regions

8. GLOBAL HEMOSTASIS AND TISSUE SEALING AGENTS MARKET ANALYSIS BY END-USE

  • 8.1. Overview By End-use
  • 8.2. Historical and Forecast Data Analysis By End-use
  • 8.3. Hospitals Historic and Forecast Sales By Regions
  • 8.4. Ambulatory Surgical Centers Historic and Forecast Sales By Regions
  • 8.5. Others Historic and Forecast Sales By Regions

9. GLOBAL HEMOSTASIS AND TISSUE SEALING AGENTS MARKET ANALYSIS BY GEOGRAPHY

  • 9.1. Regional Outlook
  • 9.2. Introduction
  • 9.3. North America Sales Analysis
    • 9.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.3.2 North America By Segment Sales Analysis
    • 9.3.3 North America By Country Sales Analysis
    • 9.3.4 United States Sales Analysis
    • 9.3.5 Canada Sales Analysis
    • 9.3.6 Mexico Sales Analysis
  • 9.4. Europe Sales Analysis
    • 9.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.4.2 Europe By Segment Sales Analysis
    • 9.4.3 Europe By Country Sales Analysis
    • 9.4.4 United Kingdom Sales Analysis
    • 9.4.5 France Sales Analysis
    • 9.4.6 Germany Sales Analysis
    • 9.4.7 Italy Sales Analysis
    • 9.4.8 Russia Sales Analysis
    • 9.4.9 Rest Of Europe Sales Analysis
  • 9.5. Asia Pacific Sales Analysis
    • 9.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.5.2 Asia Pacific By Segment Sales Analysis
    • 9.5.3 Asia Pacific By Country Sales Analysis
    • 9.5.4 China Sales Analysis
    • 9.5.5 India Sales Analysis
    • 9.5.6 Japan Sales Analysis
    • 9.5.7 South Korea Sales Analysis
    • 9.5.8 Australia Sales Analysis
    • 9.5.9 South East Asia Sales Analysis
    • 9.5.10 Rest Of Asia Pacific Sales Analysis
  • 9.6. Latin America Sales Analysis
    • 9.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.6.2 Latin America By Segment Sales Analysis
    • 9.6.3 Latin America By Country Sales Analysis
    • 9.6.4 Brazil Sales Analysis
    • 9.6.5 Argentina Sales Analysis
    • 9.6.6 Peru Sales Analysis
    • 9.6.7 Chile Sales Analysis
    • 9.6.8 Rest of Latin America Sales Analysis
  • 9.7. Middle East & Africa Sales Analysis
    • 9.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.7.2 Middle East & Africa By Segment Sales Analysis
    • 9.7.3 Middle East & Africa By Country Sales Analysis
    • 9.7.4 Saudi Arabia Sales Analysis
    • 9.7.5 UAE Sales Analysis
    • 9.7.6 Israel Sales Analysis
    • 9.7.7 South Africa Sales Analysis
    • 9.7.8 Rest Of Middle East And Africa Sales Analysis

10. COMPETITIVE LANDSCAPE OF THE HEMOSTASIS AND TISSUE SEALING AGENTS COMPANIES

  • 10.1. Hemostasis and Tissue Sealing Agents Market Competition
  • 10.2. Partnership/Collaboration/Agreement
  • 10.3. Merger And Acquisitions
  • 10.4. New Product Launch
  • 10.5. Other Developments

11. COMPANY PROFILES OF HEMOSTASIS AND TISSUE SEALING AGENTS INDUSTRY

  • 11.1. Top Companies Market Share Analysis
  • 11.2. Market Concentration Rate
  • 11.3. Johnson & Johnson
    • 11.3.1 Company Overview
    • 11.3.2 Company Revenue
    • 11.3.3 Products
    • 11.3.4 Recent Developments
  • 11.4. CryoLife Inc.
    • 11.4.1 Company Overview
    • 11.4.2 Company Revenue
    • 11.4.3 Products
    • 11.4.4 Recent Developments
  • 11.5. Advance Medical Solution (AMS) Group Plc.
    • 11.5.1 Company Overview
    • 11.5.2 Company Revenue
    • 11.5.3 Products
    • 11.5.4 Recent Developments
  • 11.6. Cohera Medical Inc.
    • 11.6.1 Company Overview
    • 11.6.2 Company Revenue
    • 11.6.3 Products
    • 11.6.4 Recent Developments
  • 11.7. Integra Life Sciences Corporation
    • 11.7.1 Company Overview
    • 11.7.2 Company Revenue
    • 11.7.3 Products
    • 11.7.4 Recent Developments
  • 11.8. Pfizer Inc.
    • 11.8.1 Company Overview
    • 11.8.2 Company Revenue
    • 11.8.3 Products
    • 11.8.4 Recent Developments
  • 11.9. BD
    • 11.9.1 Company Overview
    • 11.9.2 Company Revenue
    • 11.9.3 Products
    • 11.9.4 Recent Developments
  • 11.10. Baxter
    • 11.10.1 Company Overview
    • 11.10.2 Company Revenue
    • 11.10.3 Products
    • 11.10.4 Recent Developments
  • 11.11. HyperBranch Medical Technology
    • 11.11.1 Company Overview
    • 11.11.2 Company Revenue
    • 11.11.3 Products
    • 11.11.4 Recent Developments
  • 11.12. Biomet Inc
    • 11.12.1 Company Overview
    • 11.12.2 Company Revenue
    • 11.12.3 Products
    • 11.12.4 Recent Developments
  • 11.13. B Braun Medical Inc
    • 11.13.1 Company Overview
    • 11.13.2 Company Revenue
    • 11.13.3 Products
    • 11.13.4 Recent Developments
  • 11.14. Smith & Nephew
    • 11.14.1 Company Overview
    • 11.14.2 Company Revenue
    • 11.14.3 Products
    • 11.14.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers: Impact Analysis
  • Restraints: Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis By Product (USD MN)
  • Topical Hemostat (Active, Mechanical, Flowable) Market Sales By Geography (USD MN)
  • Adhesive & Tissue Sealant (Synthetic Tissue Sealant, Natural Tissue Sealant, Adhesion Barrier Products) Market Sales By Geography (USD MN)
  • Analysis By Material (USD MN)
  • Gelatin-Based Topical Hemostats Market Sales By Geography (USD MN)
  • Collagen-Based Topical Hemostats Market Sales By Geography (USD MN)
  • ORC-based Topical Hemostats Market Sales By Geography (USD MN)
  • Polysaccharide-Based Topical Hemostats Market Sales By Geography (USD MN)
  • Analysis By Application (USD MN)
  • General Surgery Market Sales By Geography (USD MN)
  • Neurosurgery Market Sales By Geography (USD MN)
  • Vascular Surgery Market Sales By Geography (USD MN)
  • Cardiovascular Surgery Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Analysis By End-use (USD MN)
  • Hospitals Market Sales By Geography (USD MN)
  • Ambulatory Surgical Centers Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Hemostasis and Tissue Sealing Agents Market Sales By Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United States Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate By Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Hemostasis and Tissue Sealing Agents Report
  • Market Research Process
  • Market Research Methodology
  • Global Hemostasis and Tissue Sealing Agents Market Size, By Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis By Product
  • Market Attractiveness Analysis By Material
  • Market Attractiveness Analysis By Application
  • Market Attractiveness Analysis By End-use
  • Market Attractiveness Analysis By Region
  • Value Chain Analysis
  • Global Market Analysis By Product (USD MN)
  • Topical Hemostat (Active, Mechanical, Flowable) Market Sales By Geography (USD MN)
  • Adhesive & Tissue Sealant (Synthetic Tissue Sealant, Natural Tissue Sealant, Adhesion Barrier Products) Market Sales By Geography (USD MN)
  • Global Market Analysis By Material (USD MN)
  • Gelatin-Based Topical Hemostats Market Sales By Geography (USD MN)
  • Collagen-Based Topical Hemostats Market Sales By Geography (USD MN)
  • ORC-based Topical Hemostats Market Sales By Geography (USD MN)
  • Polysaccharide-Based Topical Hemostats Market Sales By Geography (USD MN)
  • Global Market Analysis By Application (USD MN)
  • General Surgery Market Sales By Geography (USD MN)
  • Neurosurgery Market Sales By Geography (USD MN)
  • Vascular Surgery Market Sales By Geography (USD MN)
  • Cardiovascular Surgery Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Analysis By End-use (USD MN)
  • Hospitals Market Sales By Geography (USD MN)
  • Ambulatory Surgical Centers Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.